Parkinson's disease (PD) is the result of complex interactions between genetic and environmental factors. Two chemically distinct environmental stressors relevant to PD are the metal manganese and the pesticide rotenone. Both are thought to exert neurotoxicity at least in part via oxidative stress resulting from impaired mitochondrial activity. Identifying shared mechanism of action may reveal clues towards an understanding of the mechanisms underlying PD pathogenesis. Here we compare the effects of manganese and rotenone in human-induced pluripotent stem cells-derived postmitotic mesencephalic dopamine neurons by assessing several different oxidative stress endpoints. Manganese, but not rotenone caused a concentration and time-dependent increase in intracellular reactive oxygen/nitrogen species measured by quantifying the fluorescence of oxidized chloromethyl 2 0 ,7 0 -dichlorodihydrofluorescein diacetate (DCF) assay. In contrast, rotenone but not manganese caused an increase in cellular isoprostane levels, an indicator of lipid peroxidation. Manganese and rotenone both caused an initial decrease in cellular reduced glutathione; however, glutathione levels remained low in neurons treated with rotenone for 24 h but recovered in manganese-exposed cells. Neurite length, a sensitive indicator of overall neuronal health was adversely affected by rotenone, but not manganese. Thus, our observations suggest that the cellular oxidative stress evoked by these 2 agents is distinct yielding unique oxidative stress signatures across outcome measures. The protective effect of rasagiline, a compound used in the clinic for PD, had negligible impact on any of oxidative stress outcome measures except a subtle significant decrease in manganesedependent production of reactive oxygen/nitrogen species detected by the DCF assay.
to be 1 of the major factors involved in the pathogenesis of PD. Different sources of PD-associated cellular oxidative stress have been suggested, but dysfunctional mitochondria are thought to be the predominant source of reactive oxygen/nitrogen species (RONS) (Jiang et al., 2016) . Two chemically distinct environmental risk factors relevant to PD are the transition metal manganese and the pesticide rotenone (Nandipati and Litvan, 2016; Ratner et al., 2014) . Both these molecules affect mitochondrial function and owe their toxicity at least partially to the oxidative stress resulting from impaired mitochondrial activity Gavin et al., 1992; Gunter et al., 2009; Xiong et al., 2012) . Indeed, both these compounds have been reported to inhibit mitochondrial Complex I (Degli Esposti, 1998; Galvani et al., 1995; Xiong et al., 2012; Zhang et al., 2004) . The Ki values for complex I-inhibition of isolated rat brain mitochondrial by rotenone have been reported in the low nano-molar range and as low as 1 nM (Degli Esposti, 1998) . Manganese concentrations of 50-70 mM, a concentration range that lies at the transition from normal to toxic manganese levels in the human brain (Bowman and Aschner, 2014; Peres et al., 2016) , have been reported to cause a 50% inhibition of complex I activity in isolated rat brain mitochondria (Heron et al., 2001; Zhang et al., 2004) . The commonalities of the mechanism of action of manganese and rotenone may provide clues towards an understanding of the mechanisms underlying the demise of dopamine neurons characteristic for PD pathogenesis.
Manganese, is an essential trace element and plays critical roles as a co-factor for enzymes, in the modulation of the immune system, cell adhesion, protein, and carbohydrate metabolism and is required for brain development yet excessive exposure is associated with neurotoxicity (Benedetto et al., 2009; Chen et al., 2014) . Thus, excessive occupational (miners and welders), medical (total parenteral nutrition and contrast agents) or environmental (manganese containing pesticides and drinking water) exposure to manganese can lead to accumulation of this metal in the brain, especially the basal ganglia and can result in a disease termed manganism (Bouabid et al., 2016) . Although manganism shares many common features with PD such as bradykinesia and rigidity, there is little resting tremor and long-term dopaminergic pharmacotherapy is mostly ineffective (Chen et al., 2015; Neal and Guilarte, 2013) . Manganese exposure in animals does not produce an overt PD phenotype (nor do most genetic mouse models of familial PD), but does affect the functionality of the mesencephalic dopaminergic system (Neal and Guilarte, 2013) . The observations that the prevalence of PD is increased in areas where the population is exposed to naturally or industrially elevated levels of manganese (Lucchini et al., 2007; Racette et al., 2012) and, that several genes associated with increased risk for PD (ATP13A2, parkin, DJ-1, a-synuclein, SLC39A14, SLC30A10) also regulate manganese homeostasis and/or toxicity suggest a potential relevance for manganese-gene interactions for PD pathology (Chen et al., 2014; Tuschl et al., 2016) .
Manganese toxicity has been attributed to alterations in a variety of cellular functions including impairment of iron homeostasis, excitotoxicity, neurotransmitter concentrations, protein aggregation, formation of RONS, and foremost mitochondrial dysfunction (Hernandez et al., 2011; Peres et al., 2016) . Mitochondria are the main intracellular storage site for manganese (Maynard and Cotzias, 1955) , into which it is taken up via the mitochondrial Ca 2þ uniporter (Gavin et al., 1999) . In comparison to other cellular organelles, neuronal, and astrocytic mitochondria accumulate the highest relative levels of manganese after chronic exposures (Morello et al., 2008) . Increased mitochondrial manganese has been reported to result in the inhibition of oxidative phosphorylation (Gavin et al., 1992) , increased mitochondrial matrix Ca 2þ concentration (Gavin et al., 1990) and inhibition of respiratory complexes I-IV in brain mitochondria (Galvani et al., 1995; Zhang et al., 2003) all of which will ultimately result in increased RONS formation and thus oxidative stress. Rotenone, a commonly used pesticide, has been associated with increased risk for PD (Chin-Chan et al., 2015) . It is a classical, high affinity inhibitor of mitochondrial complex 1 (Degli Esposti, 1998) and believed to be a strong RONS producer (McLennan and Degli Esposti, 2000) . Systemic chronic exposure of rats to rotenone causes a selective degeneration of the substantia nigra (DA) neurons, in spite of its relatively uniform CNS distribution (Betarbet et al., 2000; Greenamyre et al., 1999; Sherer et al., 2003) . This degeneration occurs at rotenone levels which inhibit mitochondrial respiratory complex I (Betarbet et al., 2000) .
Based on the shared inhibition of mitochondrial complex I and sensitivity of the dopaminergic system to these compounds, we hypothesized, that after adjusting for dose of exposure, cellular outcome measures of oxidative stress would show similarities in DA neurons following rotenone or manganese poisoning. Here we compared the effects of manganese and rotenone on mesencephalic DA neurons derived from hiPSC and, contrary to our hypothesis, observed that these 2 toxicants, in spite of their shared action upon mitochondria, resulted in distinct neuronal oxidative stress signatures across 3 independent well established measures of oxidative stress (ie, DCF assay, generation of isoprostanes, and alteration in cellular glutathione [GSH] levels). In addition, we tested the hypothesis that rasagiline, a therapeutic used for PD (McCormack, 2014) protects iPSC-derived human mesencephalic DA neurons from manganese and rotenone-induced insults. Rasagiline is thought to afford its neuroprotective activity partially through its inhibition of monoamine oxygenase-B (MAO-B) but also by protecting mitochondrial integrity and the induction of antiapoptotic and neurotrophic factors (Naoi et al., 2013; Weinreb et al., 2011) . We did not observe detectable neuroprotective effects of rasagiline in any of our assays except of a low-magnitude, but significant reduction in manganese evoked RONS detected by DCF assay.
MATERIALS AND METHODS
Derivation, validation and differentiation of hiPSCs. hiPSCs used for this study include 5 lines obtained from 4 healthy human subjects (CA11, CC3, CD10 and CD12 and CE6; 2 letter symbols are used to identify the subject from whom the cells were derived and the number identifies the derived hiPSC line). In brief, human dermal fibroblasts were obtained by skin biopsy after appropriate patient consent/assent under the guidelines of an approved IRB protocol (Vanderbilt No. 080369 For all 5 cell lines the lack of plasmid integration into the genomic DNA was demonstrated by qPCR. Karyotype analyses were performed using standard protocols with at least 20 metaphase spreads per cell line (Genetics Associates, Nashville, Tennessee). The pluripotency of the hiPSC lines was validated by Pluritest (Muller et al., 2011) , and their capacity to differentiate into neural lineages Kumar et al., 2014; Neely et al., 2012; Tidball et al., 2015) .
Differentiation of hiPSC to a mesencephalic DA lineage was performed exactly as described (Kriks et al., 2011) except that LDN193189 (Stemgent, Lexington, Massachusetts) was used at 0.4 mM and the cells were maintained on matrigel (BD Biosciences, San Jose, California) throughout the differentiation and toxicant exposures. O just before use) was used as a positive control in the DCF assay (see below). Exposure to the toxicants/rasagiline was either in HBSS containing 25 mM glucose (for the DCF assay, see below) or floor plate neuralization medium (see above) lacking ascorbic acid.
Immunofluorescence and high content imaging. For all immunofluorescence analysis DA neurons were plated into 96-well plates (Greiner Bio-One, Monroe, North Carolina, mclear) and immunofluorescence performed as described . Briefly, the cells were fixed in PBS containing 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PZ) for 30 min at room temperature, permeabilized with 0.2% Triton X-100 for 20 min at room temperature and then incubated in PBS containing 5% donkey serum (Jackson ImmunoResearch, West Grove, Pennsylvania) and 0.05% Triton X-100 for 2 h at room temperature or overnight at 4 C. were analyzed. The absolute neurite lengths measured were subject to considerable variability, which is likely a result of the different time-line of neural differentiation and rate of neurite extension between different hiPSC lines. Thus, we observed a 2-to 3-fold difference in neurite length between different cell lines assessed within the same experiment and an up to a 3.5-fold difference in neurite length for the same cell line assessed in different experiments. The experiment to experiment variability was partially due to the fact that the interval between the replating of the neurons and neurite length assessment varied by about 24 h between experiments. Therefore, in order to make meaningful determinations of the response of the neurites to toxicants in the different experiments and different cell lines we normalized the neurite length in each experiment to the length measured in vehicle-treated control neurons.
Quantitative reverse transcription PCR (RT-qPCR).
For validation of hiPSC-lines and assessment of neural differentiation, total RNA was prepared using the RNeasy kit (Qiagen, Valencia, California) according to the manufacturer's instructions. Isolated RNA was reverse transcribed into cDNA on a Mycycler Thermal Cycler (Bio-Rad, Hercules, California) using SuperScriptIII First-Strand Synthesis System with oligo(dT) 20 (ThermoFisher) according to the protocol provided by manufacturer. Primer sequences used for RT-qPCR are provided in Supplementary Table 1 . The expression of housekeeping genes GAPDH, PGK1, UBC, and ACTIN were assessed and ACTIN and UBC expression found to be the most consistent; all mRNA signals were normalized to the expression of ACTIN mRNA. RT-qPCR was performed using a Power SYBR Green Master Mix (Applied Biosystems, Carlsbad, California) on an ABI 7900HT fast real-time PCR detection system (Applied Biosystems) in the Vanderbilt VANTAGE Core which is supported in part by CTSA Grant (5UL1 RR024975-03), the Vanderbilt Ingram Cancer Center (P30 CA68485), the Vanderbilt Vision Center (P30 EY08126), and NIH/NCRR (G20 RR030956).
Cell viability assay. To assess cell viability, we used the Cell Titer Blue assay (Promega, kit G8081) following the protocol provided by the manufacturer. This assay uses the indicator dye resazurin that is reduced in viable cells to the highly fluorescent product resorufin. Fluorescence was measured using a POLARstar Omega plate reader (BMG LABTECH, Cary, North Carolina) or a Beckman coulter DTX 880 multimode plate reader (Beckman Coulter, Brea, California). This assay is based on readings of fluorescence intensity in a plate reader and thus there are day to day variabilities resulting from type of plate reader used, and cell line dependent variabilities resulting from slight differences in cell densities and dye turnover. In order to present the data in a cohesive way and to accommodate the biological and technical variabilities we encountered all data were normalized to the vehicle treated control values. before they were loaded with 2 mM CM-H2DCFDA (ThermoFisher No. C6827) in HBSS containing 25 mM glucose for 25 min at room temperature in the dark. The cells were then washed again 2 times with HBSS before exposure. All chemicals used were diluted in HBSS containing 25 mM glucose, H 2 O 2 (Sigma) at 1 mM was used as a positive control. Fluorescence intensities were measured using a Beckman coulter DTX 880 multimode (Beckman Coulter) or a POLARstar Omega plate reader (BMG LABTECH) plate reader starting just before dye-loading (background) and then immediately after adding the toxicants (time 0 min) and then every 20 min for 4 h. This assay also is based on readings of fluorescence intensity in a plate reader and thus there are cell line-specific variabilities and day to day variabilities resulting from type of plate reader used, slight differences in cell densities, dye loading efficiencies. Thus, for the DCF assays the data are expressed (after subtracting the background fluorescence) as a fold increase relative to vehicle treated cells. Cell viability was assessed at the 4-h time point using the Cell Titer Blue assay described earlier.
GSH assay. Neurons were plated into black 96-well plates and cellular GSH levels assessed using the GSH-Glo Glutathione Assay kit (Promega, kit V6912) according to the manufacturer's protocol with the following modifications. The cells were lysed with 120 ml of 1Â passive lysis buffer (Promega, No. E1941). After a brief mixing 40 ml of the cell lysates were transferred into empty wells and 40 ml of 2Â GSH-Glo reagent added and the plates mixed and then incubated for 30 min in the dark at room temperature. Thereafter, 80 ml of Luciferin Detection reagent was added, the plates were incubated for 15 min at room temperature in the dark and then the luminescent signal was quantified using a POLARstar Omega plate reader. For each assay, we performed a standard curve with the GSH standards provided with the kit by the manufacturer; this standard curve was used to ensure that the measurements from the cell lysates were performed within the linear range of the assay and as a quality control of the kit components from day to day.
Isoprostane assay. Cells that had been replated into 6-well plates at 1Â10 6 cells per well were exposed to manganese or rotenone, washed once with HBSS, then scraped off the plates, centrifugated at 200Âg for 3 min, cell pellets flash frozen in liquid nitrogen and stored at À80 C. Total F2-Isoprostanes (F2-IsoPs) from cell pellets containing 1Â10 6 cells were isolated and quantified using gas chromatography/mass spectrometry with selective ion monitoring (GC/MS) by the Vanderbilt University Eicosanoid Core Laboratory as described in detail previously (Milatovic et al., 2011; Milne et al., 2013) . In brief, cell pellets were resuspended in 3 ml of Folch solution, sonicated, lipids extracted, and dried. The dried lipids were resuspended in 0.5 ml of methanol containing 0.005% butylated hydroxytoluene, vortexed, and then subjected to chemical saponification using 15% KOH to hydrolyze bound F2-IsoPs. The cell lysates were adjusted to pH 3, and 1 ng of 4H2-labeled 15-F2a-IsoP d4-15-F2t-IsoP (8-isoPGF2a) internal standard (Cayman Chemical; Cat. No. 316351) added as internal standard. F2-IsoPs were then purified by sequential C18-and silica Sep-Pak extraction, derivatized to the corresponding pentafluorobenzyl esters, and the derivatives separated by thin layer chromatography. The purified pentafluorobenzyl ester derivatives were further derivatized to trimethylsilyl ether derivatives, and then quantified via GC/MS. Quantification of F2-IsoPsis achieved with a precision of 66% and an accuracy of 96%. The lower limit of quantitation is 0.002 ng/ml. The content of all our samples were well within the detection limit.
Statistical analysis. DCF assay data were analyzed with 2-way ANOVA for time and treatment. Comparisons of relative changes from normalized data (cell viability, GSH level, isoprostane quantification, and neurite length) were performed by testing for nonoverlap of the 95% confidence interval with the control value (normalized ¼ 1). To assess the effects of rasagiline, comparisons of samples treated 6 rasagiline were performed by a 1-way ANOVA followed by SIDAK multiple comparison tests using GraphPad Prism software (version 5.0b, La Jolla, California).
RESULTS
Differentiation of hiPSC into Mesencephalic DA Neurons hiPSCs were differentiated into the mesencephalic DA lineage for 21-27 days. The differentiation was performed in 2 stages, a dual SMAD inhibition combined with ventral midbrain patterning resulting in floor plate cells (mesencephalic neural precursors) followed by neuronal differentiation and maturation resulting in b3-tubulin, TH, and Lmx1A expressing dopaminergic neurons (Chambers et al., 2009; Kriks et al., 2011) . The efficiency of differentiation was assessed by quantification of the expression of lineage-specific markers by immunofluoresence and qPCR (Figure 1) . At the final time point of differentiation b3-tubulin was expressed in 88 6 2.6%, Lmx1A in 89.1 6 2.1% and TH in 57.8 6 2.9% of the cells as assessed by high content imaging (Figs. 1A and B). As observed by others, Foxa2 expression was seen early peaking at day 11 and was maintained at a slightly lower level until day 25 ( Figure 1C ; Kumar et al., 2014) . Levels for b3-tubulin, a marker for postmitotic neurons and Lmx1A, Pitx3, AADC, and TH, all markers for midbrain DA neurons were highest on day 25 ( Figure 1C ) (Kriks et al., 2011; Kumar et al., 2014; Ryan et al., 2013) .
Manganese and Rotenone-Induced Oxidative Stress
We measured manganese and rotenone-induced oxidative stress by 3 independent measures within the same exposure time frame. None of the tested rotenone, manganese, and/or rasagiline exposure paradigms described in the following experiments resulted in loss of neuronal viability as measured by the Cell Titer Blue assay ( Figs. 2A and B) . In order to present the data in a cohesive way and to accommodate the biological and technical variabilities we encountered in this assay all data were normalized to the vehicle treated control values. Examples of the variability encountered between cell lines (within 1 experiment) and day to day variability are provided in Supplementary Figures 1A and B , respectively. In a first set of experiments DA neurons were preloaded with DCFH-DA and then exposed to increasing concentrations of manganese or rotenone. The oxidation of DCFH-DA to the fluorescent product DCF was measured every 20 min within a 4-h time frame. Manganese caused a concentration-and timedependent increase in cellular RONS as measured by the DCF assay in DA neurons differentiated from 4 different hiPSC lines from 4 different control subjects. F interaction (72, 728) ¼ 3.278, P < .0001; F time (12, 728) ¼ 63.71, P < .0001; F Mn conc. (6, 728) ¼ 123.2; P < .0001; mean and SEM are shown, n ¼ 9 ( Figure 3A) . Rasagiline on its own did not affect DCF fluorescence, but caused a small but significant inhibition of the manganese-induced RONS formation F ras conc . (5, 858) ¼ 494.3 (P < .0001) in DA neurons ( Figure 3B ). Turkey's multiple comparisons test indicates that the degree of inhibition was not significantly different for the 3 concentrations of rasagiline tested ( Figure 3B) . In contrast to manganese, rotenone did not induce a significant RONS production as measured by the DCF assay ( Figure 3C ). Bonferroni multiple comparisons test indicated no significant difference in RONS formation between vehicle and rotenone treated cultures, whereas H 2 O 2 used as a positive control did increase RONS formation significantly (P < .0001). The manganese-induced RONS production was specific to neurons, because no increase in a DCF signal was observed in hiPSCs exposed to manganese ( Figure 3D ), thus Bonferroni multiple comparisons test indicated no significant difference in RONS formation in control and manganese treated hiPSC cells, whereas H 2 O 2 , the positive control increased the DCF signal significantly (P < .0001). As detailed in the Methods section, all data obtained are expressed as a fold increase over vehicle-treated control cultures in order to accommodate the variabilities we observed. Examples of the variabilities we encountered with the DCF assay between cell lines within 1 experiment and from day to day (between different experiments) are provided in Supplementary Figures 2A and B. GSH is an important antioxidant protecting cells from cellular damage caused by free radicals, peroxides, and metals, and changes in intracellular levels of this tripeptide is frequently used as an indicator of the cellular redox state (Pompella et al., 2003) . We thus assessed manganese and rotenone-induced oxidative stress by determining cellular GSH (reduced) content over a time course of 2.5-24 h (Figure 4) . A 2.5-h exposure to either toxicant did not result in any significant changes in cellular GSH content ( Figure 4A ). The 5-h exposures to manganese or rotenone resulted in similar and significant decreases of cellular GSH levels ( Figure 4B ). Exposures of 24 h lead to a further loss of cellular GSH in rotenone exposed neurons, whereas, interestingly, in cells exposed to manganese for 24 h cellular GHS levels returned to control values ( Figure 4C ). Rasagiline on its own caused a slight, but significant decrease in GSH at 1 mM after a 2.5-h exposure and at 10 mM caused a small but significant increase at 5 and 24 h. An ANOVA followed by a Sidak multiple comparisons revealed no significant differences in cellular GSH levels between cultures treated with toxicants in the presence or absence of rasagiline (ANOVA followed by Sidak Multiple comparisons: F Mn, 2.5h (2, 20) ¼ 0. (Figs. 4B and C) . In addition, the effects of rotenone at 1 and 10 mM were not statistically different from each other. The variances for the GSH values at the 5-h time point were higher than at either 2.5 or the 24-h time point; we interpret this as being possibly the result of the 5-h time point representing a critical turning point in the cellular response, because in some experiments we observed significantly decreased GSH levels, whereas in other experiments GSH levels were not significantly different at the 5-h time point.
Isoprostanes are a unique series of prostaglandin-like molecules formed in a nonenzymatic free radical-initiated peroxidation of arachidonic acid and are thus a measure of lipid peroxidation. Their quantification has become a "gold standard" measure of oxidative stress (Milne et al., 2011) . To determine yet another measure of oxidative stress we quantified cellular isoprostane levels in dopamine neurons exposed to manganese or rotenone. None of the manganese treatments caused any changes in cellular isoprostane levels, rotenone exposure for 5 or 24 h led to a concentration dependent increase in cellular isoprostane levels ( Figure 5 ). Rasagiline did not protect the cells from this rotenone-induced increase in isoprostane levels nor did it affect isoprostane levels on its own ( Figure 5 ).
Effect of Manganese and Rotenone on Neurite Morphology
Changes in neurite morphology are a very sensitive measure of neurotoxicity (Krug et al., 2013) . Thus, we assessed manganese and rotenone-induced changes on b3-tubulin and TH-positive neurites. A 2-h exposure to rotenone, but not manganese causes (Figs. 6A and B) . Although Rasagiline (10 mM) appears to provide a minimal protection from this loss of b3-tubulin-and TH-positive neurites the observed trend was not statistically significant (ANOVA with Sidak's multiple comparisons test, F (7, 25) ¼ 4.658, P < .002 and TH F (7, 25) ¼ 6.208, P < .0003).
A 5-h exposure to manganese did not result in a loss of neurite length; however, a 5-h exposure to rotenone led to a loss of b3-tubulin-(at 1 and 10 mM) and of TH-neurites (at 10 mM) (Figs.  6C and D) . Rasagiline did not provide protection from this rotenone-induced neurite loss (ANOVA followed by Sidak multiple comparison test, F b3-tubulin (6, 14) ¼ 10.37, P < .0002; F TH (6, 14) ¼ 3.571, P < .03)
The rotenone-induced b3-tubulin and TH-neurite loss was increased in cultures exposed for 24 h. In cultures treated with manganese a minimal (5%) b3-tubulin loss was observed at 100 mM, but not 200 mM, whereas an equally small (5%) THneurite loss was observed at both 100 and 200 mM (Figs. 6E and  F) . Rasagiline did not protect the neurons from rotenoneinduced loss of neurite length (ANOVA followed by Sidak multiple comparison test F b3-tubulin (9, 34) ¼ 22.46, P < .0001 and F TH (9, 34) ¼ 41.90, P < .0001). 3-8) . B, A 5-h exposure to manganese or rotenone caused a small but significant decrease in cellular GSH (P < .05, n ¼ 3-11). C, A 24-h exposure results in a significant loss of cellular GSH in rotenone treated cells (P < .05), whereas cultures exposed to manganese show GSH levels return to control value (n ¼ 4-6). Shown are mean 6 95% confidence intervals. Rasagiline on its own caused a slight, but significant decrease in GSH at 1 mM after a 2.5-h exposure and at 10 mM a small but significant increase at 5 and 24 h; however, rasagiline did not affect the GSH levels in neurons treated with manganese or rotenone under any of the exposure paradigms (ANOVA followed by Sidak multiple comparisons test). 
DISCUSSION
Both manganese and rotenone induce oxidative stress mainly by interfering with mitochondrial function (Degli Esposti, 1998; Fernandes et al., 2017; Gavin et al., 1992; Gunter et al., 2009; Hernandez et al., 2011; Xiong et al., 2012; Zhang et al., 2004Xiong et al., 2012 Fernandes et al., 2017) . We thus hypothesized that exposure of DA neurons to these 2 toxicants would result in a similar pattern of cellular oxidative stress phenotypes.
The human DA neurons tested here showed no loss of viability after exposures of up to 200 mM manganese or 10 mM rotenone for 24 h; thus they are relatively more resistant to manganese than other neurons or neuronal cell lines (Stanwood et al., 2009; Stredrick et al., 2004; Yoon et al., 2011) , a characteristic that we have previously observed in hiPSCderived neural precursor cells . We are not aware of any publications assessing manganese toxicity on postmitotic mesencephalic DA neurons differentiated from hiPSC. The reported sensitivity of hiPSC-derived DA neurons to rotenone varies. Although 1 group reported mitochondrial swelling but no cell death after a 24-h exposure to 100 mM rotenone (Shaltouki et al., 2015) , several groups reported loss of hiPSC-derived DA neurons at rotenone concentrations in the range of 50-200 nM (Peng et al., 2013; Reinhardt et al., 2013; Schondorf et al., 2014; Zagoura et al., 2017) . Strikingly, in all 4 of these studies the rotenone exposure was performed in the absence, or a very low level of GDNF (1 ng/ml). The protective effect of GDNF with respect to rotenone exposure in hiPSCderived DA neurons was directly examined by Peng et al. (2013) who reported a 2-and 4-fold decrease in rotenone-induced dopamine neuronal death in the presence of 20 or 40 ng/ml of GDNF, respectively. In all our studies (except the DCF assay) GDNF was present at 20 ng/ml. In addition to the medium components, the substrate onto which the neurons are plated could also affect the response of neurons to toxicants. hiPSC-derived neurons are typically plated onto dishes coated with solutions containing laminin (1-10 mg/ml) and/or fibronectin (2-20 mg/ml) or matrigel (100 mg/ml). The different protein components and protein concentrations (and thus thickness) of these substrates could differentially bind and/or adsorb a toxicant in question and thus differentially affect the concentration of the "free" toxicant in the medium. Another variable is exposure time. We observed significant neurite loss after acute 1 mM rotenone exposures of 24 h. Fang et al., observed decreased neurite length after a 10-nM rotenone exposure but lasting 23 days, a developmental chronic exposure paradigm, during which the lipophilic rotenone could accumulate in the neurons and is thus very different from the acute 2-to 24-h exposures we used here (Fang et al., 2016) .
In addition to culture and exposure conditions the characteristics of the DA neurons likely also determine the degree of sensitivity to an oxidant stressor. Thus, Schoendorf et al. (2014) observed rotenone-induced death of hiPSC-derived DA neurons only in cell lines carrying PD-relevant mutations, but not the control cell lines, and Ryan et al., found rotenone-induced mitochondrial oxidative stress (mitoSOX signal) only in hiPSCderived DA neurons carrying PD-relevant mutations, but not in their isogenic control counter parts (Ryan et al., 2015) . In addition to the effect of genetic mutations, the maturity and thus the intracellular levels of the highly oxidizable neurotransmitter DA may play a role Farina et al., 2013) . Primary mesencephalic rodent neurons and DA neurons derived from mouse ES cells (Xiong et al., 2012; Yamashita et al., 2006) have been reported to succumb to rotenone concentrations in the range of 0.5-30 nM and appear thus generally more sensitive than their human counter parts. However, as discussed earlier, culture conditions such as GDNF (which is not typically present in the medium used for rodent neuronal cultures) can greatly affect the Sensitivity of DA neurons to rotenone making it difficult to establish species-dependent differences in toxicant sensitivities from in vitro neuronal cultures.
Here we compare manganese-and rotenone-induced oxidative stress by assessing 4 physiologically different endpoint measures. Manganese, but not rotenone caused an immediate RONS production as measured by the DCF assay, consistent with a recent report of increased H 2 O 2 production in Mn exposed SHSY5Y human neuroblastoma cells . As in our DA neurons, in PC12 cells rotenone did not cause an increase in DCF-detectable cellular RONS within the first 4 h of exposure (Seyfried et al., 2000) . Differential effects of manganese-and rotenone-induced DCFH oxidation was also observed in long-term exposures (24 h) of PC12 cells where rotenone-, but not manganese exposure resulted in elevated RONS (Hirata et al., 2006) . In contrast, in hiPSC-derived neural precursor cells long-term (24 h) manganese exposure resulted in significant RONS production as determined by measuring DCF signals . These observations suggest that in addition to toxicant exposure conditions (time), cellular DCFH oxidation upon toxicant exposure is likely also cell type specific (Bornhorst et al., 2013) . Further supporting this conclusion are our observations that the amount of manganese accumulated by cells can depend on the developmental stage and that manganese exposure of undifferentiated hiPSCs (the same lines that we differentiated into neurons here) does not result in DCFH oxidation ( Figure 3D) .
Our observation of a lack of a DCF signal in hiPSC cells treated with manganese under the exact same conditions as the neurons were exposed and the lack of a signal in the rotenone treated neurons suggests that contaminating metals potentially present in our manganese and rotenone stock solutions do not contribute a detectable intracellular DCF signal. Importantly however, we cannot exclude the possibility that endogenous transition metals (such as Fe and/or Cu) affect the manganese-induced DFC signals measured in the neurons. Assessment of the effects of transition metals (iron) on manganese-induced ROS formation in mitochondrial-synaptosomal fractions assessed by the DCF assay demonstrate that different transition metals within the same sample can indeed affect each other's redox state (HaMai and Bondy, 2004a,b; HaMai et al., 2001) .
The lack of immediate RONS production during a 4-h rotenone exposure of DA neurons was somewhat surprising. However, similar observations have been reported for other cell types and isolated rat brain mitochondria (Esposti et al., 1999; Meinel et al., 2015; Seyfried et al., 2000) . The difference between manganese-and rotenone-elicited RONS production could be due to the fact that rotenone rather specifically inhibits complex I, whereas manganese has been shown to also affect complexes II-IV and other mitochondrial enzymes (Degli Esposti, 1998; Gunter et al., 2010; Zhang et al., 2003 Zhang et al., , 2004 . RONS production reported in cells exposed to rotenone for extended times (!24 h) could be the result of secondary effects such as loss of stability of mitochondrial membrane potential, energy depletion, and cellular signaling (Pal et al., 2014; Radad et al., 2006) . Cellular GSH levels of hiPSC-derived DA neurons were also differentially affected by manganese and rotenone. Although short-term exposures (2.5 h) had no effect on GSH levels in cells treated with manganese or rotenone, 5-h exposures caused a similarly small and significant decrease in cellular GSH in manganese and rotenone exposed neurons. However, after a 24-h exposure GSH levels had recovered to control levels in manganese treated cells, but further decreased in rotenone exposed neurons. An initial decline, followed by a recovery of GSH levels has also been reported for manganese-exposed PC12 cells (Desole et al., 1997) and normal GSH levels were observed in primary cultures of rodent neurons after long-term (5 days) manganese exposures (Hernandez et al., 2011) . The rotenone-induced persistent loss of GSH we observed in our study is similar to observations made in PC12 cells and human neuroblastoma cells (Seyfried et al., 2000; Sherer et al., 2002) . These observations suggest that human neurons are able to, over time (here within 24 h), adapt to elevated manganese at least with regard to restoration of intracellular GSH levels, whereas in neurons treated with rotenone, this appears not to be the case, further suggesting that the oxidative stress pathways and their downstream targets are likely different for these 2 compounds.
F2-isoprostane levels, a measure of lipid peroxidation, were also differentially affected by manganese and rotenone. None of the manganese exposure paradigms tested resulted in a change of F2-isoprostanes in our hiPSC-derived DA neurons, whereas incubation with rotenone caused a concentration-and timedependent increase in these indicators of lipid peroxidation. Elevated levels of F2-isoprostanes have been observed in brains of patients with neurodegenerative disease (Montine et al., 2004) , but to our knowledge our study is the first to assess F2-isoprostane levels in hiPSC-derived neurons and to report distinctly different levels of these indicators of lipid peroxidation upon exposure to these 2 different PD-relevant oxidative stressors.
Changes in cell morphology, and neurite extension in particular, are key indicators of neuronal health (Krug et al., 2013) . While manganese had only a very slight effect after a 24-h exposure, rotenone induced a time, and concentration-dependent decrease in neurite length. Rotenone-induced neurite loss occurred after exposure times and at rotenone concentrations, for which we did not see indication of oxidative stress as measured by DCF, GSH or F2-isoprostane levels suggesting that rotenoneinduced neurite retraction occurs independent of oxidative stress. In addition, to its well characterized inhibition of mitochondrial complex I activity, rotenone binds directly to tubulin and causes microtubule depolymerization (Jiang et al., 2006b; Ren et al., 2005) . The earliest pathological feature of in vivo rotenone exposed rodents is the loss of distal DA processes (Betarbet et al., 2000; Jiang et al., 2006a) . Rotenone-induced neurite loss in rodent mesencephalic primary cultures has been shown to be a result of microtubule depolymerization, and both, loss of neurites and microtubules, were ameliorated by BDNF or GDNF (Jiang et al., 2006b; Ren et al., 2005) . The DA neurons in our study were exposed to rotenone in the presence of BDNF and GDNF at concentrations similar to the ones reported to be protective in cultured rodent neurons, an observation that suggests that either these neurotrophic factors do not serve the same function, or higher concentrations are required for the protection of human neurons. Neurite loss caused by a direct interaction between rotenone and tubulin would also explain the similar sensitivity of b3-tubulin-and TH-positive neurites observed in our study.
Rasagiline, a therapeutic used in the clinic for PD provided a small, but significant protection against the initial manganeseinduced RONS formation as measured by the DCF assay. Rasagiline did not provide protection against rotenone-or manganese-induced loss of cellular GSH, formation of isoprostanes or loss of neurites. Rasagiline, at concentrations similar to the ones we used have been reported to afford a moderate protection in hiPSC-derived DA neurons and PC12 cells from rotenone-induced loss of neuronal viability as measured by MTT assay and/or immunostaining (Milusheva et al., 2010; Peng et al., 2013) .
We show here that manganese and rotenone, which both are believed to interfere with mitochondrial function, particularly inhibition of mitochondrial complex I, exert distinctive cellular oxidative stress phenotypes on human dopaminergic neurons as determined by 3 methodologically and mechanistically different measures. Although rotenone is viewed as a classical complex I inhibitor (but also interferes with microtubules see the Discussion section above), manganese has been reported to affect several other cellular functions. Manganese 2þ/3þ have very different valence states and unusual ionic properties when compared with other transition metals such as iron 2þ/3þ and Copper 1þ/2þ . Manganese is known to affect the redox balance of other transition metals such as iron and copper, and indirectly modulates redox reactions driven by these metals (HaMai and Bondy, 2004a,b; HaMai et al., 2001) . Thus, variations in intracellular manganese concentrations could globally impact the redox environment of the cell, indeed manganese has been referred to as the "hub within the global redox network" (Smith et al., 2017) . Such an effect on transition metals by rotenone is not likely. Excess manganese can also dysregulate cellular iron regulation thereby increasing the intracellular labile iron pool (Kwik-Uribe et al., 2003) . In addition to its effects on other cellular metals, manganese can cause oxidative stress in dopaminergic neurons by catalyzing the autoxidation of dopamine, a reaction which produces cytotoxic quinones and free radicals Farina et al., 2013) . The accumulation of manganese has also been postulated to lead to an exhaustion of cellular antioxidant defenses, result in oxidative damage of proteins, polyunsaturated fatty acids and nuclear and mitochondrial DNA (HaMai and Bondy, 2004a; Jellinger, 2013) . Lastly, RONS resulting from excess manganese could interfere with redox-sensitive signaling pathways (HaMai and Bondy, 2004a; Jellinger, 2013) . Thus, albeit manganese and rotenone share an inhibition of mitochondrial complex I, some/or all of the above-outlined mechanisms by which manganese can cause oxidative stress could contribute to the different oxidative stress signatures we observed for rotenone and manganese. Our studies thus support the hypothesis that oxidative stress manifests in different ways depending on the stressor of choice, exposure condition and cell types assessed. As such, the determination of the capacity and potency of a compound to induce oxidative stress in a cell type of choice is more accurately described using a combination of oxidative stress measures, to define its cellular oxidative stress signature. This point is exemplified by the failure of the "gold-standard" oxidative stress measure, isoprostane analysis (Milatovic et al., 2011; Milne et al., 2011; Yin, 2008) , to detect manganese-induced oxidative stress which otherwise manifested itself in alterations in cellular GSH levels and RONS production quantified by the DCF assay.
Interestingly, our observations in early postmitotic human DA neurons in vitro mirror the dissimilarities of DA neuron responses to manganese and rotenone in vivo. Manganese has been shown to affect dopamine release in some in vivo models but it does not appear to affect DA synaptic morphology or neurite degeneration, and loss of nigral DA neurons is not a common feature (Guilarte, 2010; Kwakye et al., 2015) . Chronic low dose exposure of rodents to rotenone on the contrary has an early and severe effect on mesencephalic DA nerve terminals and axons followed by a later selective loss of TH-positive cell bodies in the substantia nigra (Betarbet et al., 2000; Greenamyre et al., 1999; Sherer et al., 2003) . The most sensitive rotenoneinduced neuronal response (neurite retraction) we reported here is thus similar to what has been reported in mouse models of PD and is observed in brains of PD patients, where the loss of dopamine is significantly greater in the striatum than in the substantia nigra and DA axons and their terminals appear to be the earliest and principal site of PD pathology (Cheng et al., 2010; Hornykiewicz, 1966) .
SUPPLEMENTARY DATA
Supplementary data are available at Toxicological Sciences online. 
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